Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
17 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/17/3116959/0/en/Nicox-and-Kowa-Sign-Key-Agreement-worth-up-to-191-5-million-for-Exclusive-Rights-to-Glaucoma-Treatment-NCX-470-in-U-S-and-all-Unlicensed-Territories.html
12 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ocumension-acquires-rights-to-alcon-eye-drops-in-exchange-for-a-16-7-equity-stake-signaling-the-commencement-of-comprehensive-strategic-relationship-302219955.html
12 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ocumension-01477hk-demonstrates-strong-operational-resilience-commercialization-capabilities-reach-new-heights-302219944.html
23 Jun 2022
// BIOSPECTRUMASIA
https://www.biospectrumasia.com/news/25/20560/china-approves-treatment-for-chronic-non-infectious-eye-inflammation.html
22 Jun 2022
// Nick Paul Taylor FIERCEPHARMA
https://www.fiercepharma.com/pharma/first-china-approves-eye-implant-based-solely-real-world-data
20 Aug 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/ocumension-therapeutics-announces-2021-interim-results-301359820.html
ABOUT THIS PAGE